Health · STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
Benchmarking clinical LLMs from OpenEvidence and Doximity proves complicated
Sourcing
Mixed sourcing
7 claims: 7 with no supporting source.
Why it matters
As clinical chatbots proliferate in healthcare settings, the difficulty of establishing reliable performance benchmarks raises questions about how providers and patients can evaluate these AI tools before adoption.
Evaluating clinical large language models from companies like OpenEvidence and Doximity presents significant challenges, according to a new analysis. The complexity stems from the specialized nature of medical knowledge and the high stakes of clinical decision-making, where standard AI benchmarks may not capture real-world performance. The benchmarking discussion comes amid broader debates about AI's role in medicine, with healthcare professionals expressing concerns about how these tools affect clinical practice. Nurses warn that clinical AI threatens both their jobs and patient safety, while physicians argue that AI systems reflect an ongoing erosion of medical judgment rather than enhancing professional autonomy.
Grounding — every claim checked against sources
0 / 7 grounded
OpenEvidence and Doximity are companies that have developed clinical large language models.
NO SOURCEEvaluating clinical large language models presents significant challenges.
NO SOURCEStandard AI benchmarks may not capture real-world performance of clinical LLMs.
NO SOURCEHealthcare professionals have expressed concerns about how clinical AI tools affect clinical practice.
NO SOURCENurses have warned that clinical AI threatens their jobs.
NO SOURCEDon't take our word for it
Run any claim in this Brief through Citelink's verification engine yourself.